Abstract
Severe lymphoproliferative disease (SLD) developed in 19 of the 1850 patients treated by kidney or kidney and pancreas transplantation in our institution. This type of malignancy could be reversed in some patients by early tapering of immunosuppressive therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blanche S, Le Deist F, Veber F et al. (1987) Treatment of EBV induced B lymphocyte proliferation by anti-B cell monoclonal antibodies. Bone Marrow Transplant 2 (Suppl 1):265
Chapuis-Cellier C, Francina A, Arnaud P (1980) In: Radola BJ (ed) Electrophoresis 79, de Gruyter, Berlin, p 711
Cleary ML, Sklar J (1984) Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet 2:489
Cleary ML, Warnke R, Sklar J (1984) Monoclonality of lymphoproliferative lesions in cardiac transplant recipients: clonal analysis based on immunoglobulin-gene rearrangements. N Engl J Med 310:477
Deteix P, Chapuis-Cellier C, Ghais Z et al. (1985) Systematic survey of immunoglobulin abnormalities; frequency and evolution in organ transplant recipients. Transplant Proc 17:2651–2654
Hanto DW, Gajl-Peczalska KI, Frizzera G et al. (1983) Epstein-Barr (EBV) induce polyclonal and monoclonal T cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathological and virological findings and implication for therapy. Ann Surg 198:356–68
Penn I (1979) Tumor incidence in human allograft recipients. Transplant Proc 11:1047–1051.
Penn I (1987) Neoplastic consequences of transplantation and chemotherapy. Cancer Detect Prev (Suppl 1): 149–157
Radl J, Adler WH, Nordin AA, Adelman RC et al. (1981) Immunological techniques applied to aging research. CRC Press, Boca Raton, Fl, p 121
Starzl TE, Nalesnik MA, Porter KA et al. (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under Cyclosporin-steroid therapy. Lancet: 583–587
Touraine JL, Traeger J (1985) Severe lymphoproliferation of viral origin in immuno-suppressed patients. Revue Institut Pasteur Lyon 18:109–115
Touraine JL, Traeger J (1987) Malignant lymphoproliferative disorders of viral origin in transplant patients undergoing immunosuppressive therapy. Cancer Detect Prev (Suppl 1): 159–164
Touraine JL, El Yafi S, Bosi E et al. (1983) Immunoglobulin abnormalities and infectious lymphoproliferative syndrome (ILPS) in Cyclosporin-treated transplant patients. Transplant Proc 15 (Suppl 1): 2798–2804
Touraine JL, Deteix P, El Yafi M et al. (1987) Virus-induced lymphomas in transplant patients under immunosuppressive therapy. Transplant Proc 19:4087–4088
Touraine JL, Gamier JL, Lefrançois N et al. (1989) Severe lymphoproliferative disease and Kaposi sarcoma in transplant patients. Transplant Proc 21:3197–3198
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Touraine, JL. (1991). Malignant Lymphoproliferation of Viral Origin in Transplant Patients. In: Schmähl, D., Penn, I. (eds) Cancer in Organ Transplant Recipients. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75991-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-75991-8_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-53020-6
Online ISBN: 978-3-642-75991-8
eBook Packages: Springer Book Archive